Venture Life Group (LON:VLG) Hits New 12-Month High – Time to Buy?

Shares of Venture Life Group plc (LON:VLG) reached a new 52-week high during trading on Monday . The company traded as high as GBX 68 and last traded at GBX 66.85, with a volume of 404085 shares. The stock had previously closed at GBX 65.51.

Venture Life Group Stock Performance

The company has a debt-to-equity ratio of 28.45, a quick ratio of 1.48 and a current ratio of 2.22. The stock has a market cap of £84.67 million, a PE ratio of -87.96, a PEG ratio of 5.67 and a beta of 0.30. The company’s 50-day moving average price is GBX 63.50 and its two-hundred day moving average price is GBX 59.46.

Insiders Place Their Bets

In other Venture Life Group news, insider Jerry Randall sold 387,705 shares of the firm’s stock in a transaction dated Friday, January 9th. The stock was sold at an average price of GBX 66, for a total transaction of £255,885.30. 6.86% of the stock is owned by insiders.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market.

With operations in the UK, The Netherlands and Italy, the Group’s product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women’s intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.